AMBROSE AVENUE GROUP PRACTICE
76 AMBROSE AVENUE, COLCHESTER
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 20 | 29 | 69.0% | |
| HF 4 | 2011 | 17 | 23 | 73.9% | |
| HF 4 | 2012 | 25 | 32 | 78.1% | |
| HF 4 | 2013 | 29 | 37 | 78.4% | |
| HF004 | 2014 | 18 | 20 | 90.0% | |
| HF004 | 2015 | 19 | 22 | 86.4% | |
| HF004 | 2016 | 22 | 23 | 95.7% | |
| HF004 | 2017 | 23 | 24 | 95.8% | |
| HF004 | 2018 | 32 | 34 | 94.1% | |
| HF004 | 2019 | 29 | 33 | 87.9% | |
| HF004 | 2020 | 33 | 38 | 86.8% | |
| HF006 | 2021 | 37 | 44 | 84.1% | |
| HF006 | 2022 | 34 | 36 | 94.4% | |
| HF006 | 2023 | 45 | 48 | 93.8% |
